Rini BI - Search Results

1

Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma.

Koshkin VS, Barata PC, Zhang T, George DJ, Atkins MB, Kelly WJ, Vogelzang NJ, Pal SK, Hsu J, Appleman LJ, Ornstein MC, Gilligan T, Grivas P, Garcia JA, Rini BI. Koshkin VS, et al. Among authors: rini bi. J Immunother Cancer. 2018 Jan 29;6(1):9. doi: 10.1186/s40425-018-0319-9. J Immunother Cancer. 2018. PMID: 29378660 Free PMC article.

2

Granulocyte-macrophage--colony stimulating factor in metastatic renal cell carcinoma: a phase II trial.

Rini BI, Stadler WM, Spielberger RT, Ratain MJ, Vogelzang NJ. Rini BI, et al. Cancer. 1998 Apr 1;82(7):1352-8. doi: 10.1002/(sici)1097-0142(19980401)82:7<1352::aid-cncr19>3.0.co;2-5. Cancer. 1998. PMID: 9529028 Clinical Trial.

3

Phase I study of direct intralesional gene transfer of HLA-B7 into metastatic renal carcinoma lesions.

Rini BI, Selk LM, Vogelzang NJ. Rini BI, et al. Clin Cancer Res. 1999 Oct;5(10):2766-72. Clin Cancer Res. 1999. PMID: 10537340 Clinical Trial.

4

Prognostic factors in renal carcinoma.

Rini BI, Vogelzang NJ. Rini BI, et al. Semin Oncol. 2000 Apr;27(2):213-20. Semin Oncol. 2000. PMID: 10768600 Review.

5

Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer.

Rini BI, Vogelzang NJ, Dumas MC, Wade JL 3rd, Taber DA, Stadler WM. Rini BI, et al. J Clin Oncol. 2000 Jun;18(12):2419-26. doi: 10.1200/JCO.2000.18.12.2419. J Clin Oncol. 2000. PMID: 10856102 Clinical Trial.

6

Allogeneic peripheral blood stem cell transplantation for metastatic renal cell carcinoma.

Rini BI, Zimmerman TM, Gajewski TF, Stadler WM, Vogelzang NJ. Rini BI, et al. J Urol. 2001 Apr;165(4):1208-9. J Urol. 2001. PMID: 11257677 No abstract available.

7

A phase II trial of weekly intravenous gemcitabine and cisplatin with continuous infusion fluorouracil in patients with metastatic renal cell carcinoma.

George CM, Vogelzang NJ, Rini BI, Geoffroy FJ, Kollipara P, Stadler WM. George CM, et al. Among authors: rini bi. Ann Oncol. 2002 Jan;13(1):116-20. doi: 10.1093/annonc/mdf008. Ann Oncol. 2002. PMID: 11863091 Free article. Clinical Trial.

8

Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results.

Rini BI, Zimmerman T, Stadler WM, Gajewski TF, Vogelzang NJ. Rini BI, et al. J Clin Oncol. 2002 Apr 15;20(8):2017-24. doi: 10.1200/JCO.2002.08.068. J Clin Oncol. 2002. PMID: 11956260 Clinical Trial.

9

Flt-3 ligand and sequential FL/interleukin-2 in patients with metastatic renal carcinoma: clinical and biologic activity.

Rini BI, Paintal A, Vogelzang NJ, Gajewski TF, Stadler WM. Rini BI, et al. J Immunother. 2002 May-Jun;25(3):269-77. doi: 10.1097/00002371-200205000-00010. J Immunother. 2002. PMID: 12000869 Clinical Trial.

10

A high rate of venous thromboembolism in a multi-institutional phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma.

Desai AA, Vogelzang NJ, Rini BI, Ansari R, Krauss S, Stadler WM. Desai AA, et al. Among authors: rini bi. Cancer. 2002 Oct 15;95(8):1629-36. doi: 10.1002/cncr.10847. Cancer. 2002. PMID: 12365009 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

523 results

Search Page

Filters